West Pharmaceutical Services (WST) Net Cash Flow (2016 - 2025)
Historic Net Cash Flow for West Pharmaceutical Services (WST) over the last 17 years, with Q4 2025 value amounting to $163.3 million.
- West Pharmaceutical Services' Net Cash Flow rose 89573.17% to $163.3 million in Q4 2025 from the same period last year, while for Dec 2025 it was $283.8 million, marking a year-over-year increase of 18157.52%. This contributed to the annual value of $283.8 million for FY2025, which is 18157.52% up from last year.
- Per West Pharmaceutical Services' latest filing, its Net Cash Flow stood at $163.3 million for Q4 2025, which was up 89573.17% from $122.4 million recorded in Q3 2025.
- Over the past 5 years, West Pharmaceutical Services' Net Cash Flow peaked at $163.3 million during Q4 2025, and registered a low of -$243.4 million during Q1 2024.
- In the last 5 years, West Pharmaceutical Services' Net Cash Flow had a median value of $34.1 million in 2022 and averaged $9.5 million.
- Its Net Cash Flow has fluctuated over the past 5 years, first crashed by 152266.67% in 2024, then soared by 89573.17% in 2025.
- West Pharmaceutical Services' Net Cash Flow (Quarter) stood at $77.2 million in 2021, then surged by 63.86% to $126.5 million in 2022, then tumbled by 146.8% to -$59.2 million in 2023, then surged by 127.7% to $16.4 million in 2024, then soared by 895.73% to $163.3 million in 2025.
- Its Net Cash Flow was $163.3 million in Q4 2025, compared to $122.4 million in Q3 2025 and $87.0 million in Q2 2025.